Cargando…

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

BACKGROUND: Treatment with anti-tuberculosis drugs may cause patients to experience serious adverse effects. Genetic factors, such as polymorphisms of CYP genes, may increase the likelihood of a patient experiencing such adverse drug reactions. In this systematic review and meta-analysis, we synthes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Marty, Kirkham, Jamie, Dwan, Kerry, Sloan, Derek J., Davies, Geraint, Jorgensen, Andrea L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247669/ https://www.ncbi.nlm.nih.gov/pubmed/30458875 http://dx.doi.org/10.1186/s13643-018-0861-z

Ejemplares similares

Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)
por: Richardson, Marty, et al.
Publicado: (2017)

Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
por: Richardson, Marty, et al.
Publicado: (2019)

NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis
por: Richardson, M., et al.
Publicado: (2019)

STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
por: Chaplin, Marty, et al.
Publicado: (2020)

The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents
por: Zuniga, Edison S., et al.
Publicado: (2017)

Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents
por: Kesicki, Edward A., et al.
Publicado: (2016)

Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeys
por: Bruning-Barry, Rebecca, et al.
Publicado: (2022)

Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-Tubercular Agents
por: Choi, Won Hyung
Publicado: (2017)

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias — An Updated Review
por: Dwan, Kerry, et al.
Publicado: (2013)

Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis
por: Dwan, Kerry, et al.
Publicado: (2013)

Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
por: Alsayed, Shahinda S. R., et al.
Publicado: (2020)

Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2022)

Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review
por: Tella, Josephine Oluwagbemisola, et al.
Publicado: (2022)

Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents
por: Srinivasarao, Singireddi, et al.
Publicado: (2020)

Paradoxical response to anti-tubercular treatment
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Unfamiliar Manifestations of Anti-tubercular Therapy
por: Aggarwal, Ramesh, et al.
Publicado: (2014)

Correction: Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents
por: Srinivasarao, Singireddi, et al.
Publicado: (2020)

How Much Participant Outcome Data Is Missing from Sight: Findings from a Cohort of Trials Submitted to a German Research Ethics Committee
por: Kirkham, Jamie J., et al.
Publicado: (2016)

Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents
por: Nalla, Viswanadh, et al.
Publicado: (2018)

Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents
por: Adeniji, Shola Elijah, et al.
Publicado: (2020)

1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation
por: Ashok, Dongamanti, et al.
Publicado: (2018)

Anti-tubercular derivatives of rhein require activation by the monoglyceride lipase Rv0183
por: Abrahams, Katherine A., et al.
Publicado: (2020)

AntiTbPdb: a knowledgebase of anti-tubercular peptides
por: Usmani, Salman Sadullah, et al.
Publicado: (2018)

Feasibility study to examine discrepancy rates in prespecified and reported outcomes in articles submitted to The BMJ
por: Weston, Jennifer, et al.
Publicado: (2016)

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews
por: Kirkham, Jamie J, et al.
Publicado: (2018)

The anti-tubercular activity of Melia azedarach L. and Lobelia chinensis Lour. and their potential as effective anti-Mycobacterium tuberculosis candidate agents
por: Choi, Won Hyung, et al.
Publicado: (2016)

Synthesis and Evaluation of New Fluorinated Anti-Tubercular Compounds
por: Esfahanizadeh, Marjan, et al.
Publicado: (2014)

Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach
por: Brown, Alistair K., et al.
Publicado: (2020)

'Tubercular' and 'Tuberculous'
Publicado: (1939)

Tubercular Iritis
por: Pollock, W. B. Inglis
Publicado: (1904)

Tubercular Leprosy
por: Labonté, J.
Publicado: (1880)

Tubercular Leprosy
por: Labonté, J.
Publicado: (1878)

Tubercular Leprosy
por: Labonté, J.
Publicado: (1877)

Tubercular Neuritis
por: James, Alexander
Publicado: (1899)

Tubercular Pneumonia
por: Condie, D. Francis
Publicado: (1871)

Tubercular Peritonitis
por: Crofford, T. J.
Publicado: (1892)

Tubercular Meningitis
por: Hodges, J. Allison
Publicado: (1897)

Tubercular Meningitis
por: Mattsen, W. H.
Publicado: (1894)

Tubercular Kidneys
Publicado: (1869)

Tubercular Meningitis
por: Earle, Chas. W.
Publicado: (1879)

Cannot write session to /tmp/vufind_sessions/sess_prs2kfu16t6margb94aal3ttcc